Sign In
Free Newsletter
Central Va. pharma hub strategic plan released
On Tuesday, the Virginia Commonwealth University College of Engineering announced its strategy to turn Central Virginia into an advanced pharmaceutical manufacturing, research and development hub. The strategic plan aims to foster business and job growth in the Richmond–Petersburg area while also expanding access to medicines. The creation of the plan was funded by a $100,000 […]
Phlow announces national coalition with children’s hospitals
Richmond-based Phlow Corp. announced Thursday the launch of a coalition that will help ensure that children’s hospitals across the country receive key medications. The Virginia Commonwealth University-affiliated Children’s Hospital of Richmond is one of 11 founding hospital members. Children’s Hospital Coalition (CHC) aims to provide certainty in availability and access to medici[...]
$125M pharma manufacturing plant coming to Petersburg
Utah-based pharmaceutical manufacturer Civica Inc. plans to invest $124.5 million to establish its North American manufacturing headquarters operation in Petersburg, creating 186 jobs and manufacturing injectable medicines for the treatment of COVID-19, the governor’s office announced Thursday. A nonprofit generic drug company, Civica was established in 2018 by a group of U.S. health systems[...]
Trump administration chooses RVA pharma startup for $354M COVID-19 contract
Richmond-based drug manufacturing company Phlow Corp., which incorporated this year, announced Tuesday that the Trump administration has awarded it a $354 million, four-year contract to manufacture in the U.S. generic medicines and pharmaceutical ingredients needed to treat COVID-19, creating an American supply chain for medical products that are now made mostly in China and India. […]
